TRENARY C RUSSELL III
SEC CIK 1227307 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | CEO, Pres, Dir | 54.9K | $69.9K | — | 3 | 2021-12-02 | 2022-06-21 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
TRENARY C RUSSELL III made no open-market trades at OTLK in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-23 | 2022-06-21 | OTLK | Outlook Therapeutics, Inc. | TRENARY C RUSSELL III | CEO, Pres, Dir | P - Purchase | $1.06 | +19.9K | 54.9K | +57% | +$21.1K | |
| 2021-12-06 | 2021-12-06 | OTLK | Outlook Therapeutics, Inc. | TRENARY C RUSSELL III | CEO, Pres, Dir | P - Purchase | $1.39 | +25.0K | 35.0K | +250% | +$34.8K | |
| 2021-12-02 | 2021-12-02 | OTLK | Outlook Therapeutics, Inc. | TRENARY C RUSSELL III | CEO, Pres, Dir | P - Purchase | $1.40 | +10.0K | 10.0K | New | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations